The acceleration of research focused on dry eye over the past several decades has led to an increase in knowledge regarding the pathophysiology of the disease.
George W. Ousler III
Advertisement
Articles by George W. Ousler III
Dry eye syndrome has been estimated to affect more than 5 million Americans, yet there is only one FDA-approved eye drop, cyclosporine ophthalmic emulsion 0.05%, for its treatment.
Advertisement
Latest Updated Articles
- Dry eye brimming with innovation
May 1st 2012
- Dry eye pipeline full of potential
April 1st 2011
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA guidance to help accelerate cell and gene therapies
2
Oculis phase 3 DIAMOND trials miss vision endpoints in diabetic macular edema
3
The Residency Report: Cardiovascular risk scores as a window into ocular disease
4
TearSolutions advances Lacripep into phase 2 following dual FDA designations in neurotrophic keratitis
5